ClinicalTrials.gg
Sign In
Drug

Tedizolid clinical trials

Includes 29 studies of Tedizolid phosphate.

studies test it
34
open now
2
in phase 3
7
first study started
2008

How each study uses tedizolid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the tedizolid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States
20 Jun 2014 · SIVEXTRO · NDA 205435 (FDA, Drugs@FDA; as tedizolid phosphate)
European Union
23 Mar 2015 · Sivextro · EMEA/H/C/002846 (EMA; as tedizolid phosphate)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Tedizolid
4
Sivextro
2

Studies by the year they started

34 studies that test it; most in 2012 (5)

Studies that test tedizolid, by start year
YearStudies
20084
20091
20103
20114
20125
20131
20143
20154
20162
20171
20181
20192
20222
20231

By phase

A phase 1/2 study counts in both.

Phase 1
19
Phase 2
4
Phase 3
7
Phase 4
3
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Skin Diseases, Bacterial
3
Bacterial Infections
3
Cystic Fibrosis
1
Gram-Positive Bacterial Infections
1
Pneumonia
1
Skin Diseases, Infectious
1
Cellulitis
1
Obesity
1
Endocarditis
1
Tuberculosis, Multidrug-Resistant
1

Who runs them

Industry 27 · Other 7

Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (17) · Merck Sharp & Dohme LLC (5) · Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (2) · Bayer (2) · Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (1) · Tourcoing Hospital (1) · University of Southern California (1) · Dong-A ST Co., Ltd. (1)

Often tested with

Tested in the same studies.

Linezolid (2) · Tyramine (1) · Midazolam (1) · Rosuvastatin (1) · Cefaclor (1) · Ciprofloxacin (1) · Clindamycin (1) · Dicloxacillin (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test tedizolid.

Studies

Open first, then newest update. How each study uses tedizolid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 34

See all 34 studies that test tedizolid →

Given beside what is tested · 1 — tedizolid is usual care or a partner of the new treatment

Codes

What other systems call tedizolid · ClinicalTrials.gg INT005549

  • MeSH (NLM) C546016tedizolidConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 97HLQ82NGLTEDIZOLIDConfirmed FDA, NLM, Wikidata
  • RxNorm 1540825Confirmed FDA, Wikidata
  • Wikidata Q7825683tedizolidConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C84222TedizolidOne source FDA
  • DrugBank DB14569One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.